Aballéa, S., Maman, K., Thokagevistk, K., Nazir, J., Odeyemi, I. A. O., Hakimi, Z., . . . Toumi, M. (2014). Cost Effectiveness of Mirabegron Compared with Tolterodine Extended Release for the Treatment of Adults with Overactive Bladder in the United Kingdom. Clin Drug Investig.

Aballéa, Samuel, Khaled Maman, Katia Thokagevistk, Jameel Nazir, Isaac A. O. Odeyemi, Zalmai Hakimi, Andy Garnham, and Mondher Toumi. "Cost Effectiveness of Mirabegron Compared With Tolterodine Extended Release for the Treatment of Adults With Overactive Bladder in the United Kingdom." Clin Drug Investig 2014.

Aballéa, Samuel, et al. "Cost Effectiveness of Mirabegron Compared With Tolterodine Extended Release for the Treatment of Adults With Overactive Bladder in the United Kingdom." Clin Drug Investig 2014.